National initiatives and biobanks have been driving the genomics transformation for years – however these efforts have been fraught with major challenges […]

Open science in COVID-19 research has become one of the most powerful tools in the global fight against the pandemic. In Week […]

It’s been just 5 weeks since COVID-19 was declared a pandemic by the World Health Organisation (on March 11th to be exact) […]

Research is continuing to move quickly on the COVID-19 frontlines and we’re here again to bring you the latest developments and resources […]

At Lifebit, we are closely involved in the scientific community and the almost daily evolving COVID-19 developments. Our team is actively engaged […]

In light of recent developments surrounding the novel coronavirus (COVID-19) global outbreak, researchers around the world are generating clinical, epidemiological and sequencing […]

Accelerating Genomics and Bioinformatics Advancements Recent studies highlight the impact of genomics and bioinformatics advancements in various fields. The surge in genomics […]

I have had the opportunity to get to know a great many people in life sciences. Whether pharmaceutical, biotechnology, or direct-to-consumer (DTC) […]

Why study cancer heterogeneity? Introducing HotNet2, a cancer gene detection algorithm, to support your efforts. Understanding a cancer gene detection algorithm is […]

There are 3,000,000,000 base pairs in the human genome, which define our individual code. 99% of these are identical for all humans- […]

Comparison of three different imputation pipelines: The good, the bad & the ugly In this article, we will explore the best practices for […]